MarginsXMarginsX
Home › Markets › Health Care › BLCO

Bausch + Lomb Corporation Common Shares (BLCO)

BLCO trades on NYSE in Health Care, Ophthalmic Goods. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$20.88
-1.00% on the day
Market cap
$7.5B
Mid cap
Revenue · 2025
$5.1B
+6.5% on 2024
Net income · 2025
-$360.0M
-7.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1860742/000186074226000007/0001860742-26-000007-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerBLCO on NYSE
SectorHealth Care
IndustryOphthalmic Goods
CountryNot reported by the screener
IPO year2022
SEC CIK0001860742
SEC industry codeOphthalmic Goods
Canadian listingTSX: BLCO

Financials · 2025

LineValue
Revenue$5.1B
Net income-$360.0M
Operating income$113.0M
Net margin-7.1%
Operating margin2.2%
Revenue growth+6.5%
Cash$383.0M
Total assets$14.0B
P/E (computed)Net income was not positive
P/S (computed)1.5×

Warning signs

Cash runway
Cash-flow positive
$513.0M cash at September 30, 2026
Share count, 1 year
+0.9%
2025-10-22 to 2026-10-21 · +1.9% over 3 years
Going-concern doubt
No
10-Q filed October 28, 2026
Insider net buying, 12 months
$30K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-28
Cash and burn$513.0M cash; operating cash flow $138.5M a quarter.Report 2026-09-30
Shares outstanding357,497,374 (2026-10-21); 354,189,784 a year earlier; 350,855,769 three years earlier.Cover page 2026-10-21
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Florham Park, New Jersey, United StatesPCAOB Form AP 2026-03-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $1.2M, sold $1.2M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$1.4B$32.0M$233.0M$513.0M$5.0B$5.4B10-Q 2026-10-28
Q2 2026
2026-06-30
$1.4B-$14.0M$153.0M$367.0M$5.1B$5.3B10-Q 2026-07-29
Q1 2026
2026-03-31
$1.2B-$71.0M$32.0M$268.0M$5.0B$5.2B10-Q 2026-04-29
Q4 2025
2025-12-31
$1.4B-$58.0M$136.0M$383.0M$5.0B$5.1B10-K 2026-02-18
Q3 2025
2025-09-30
$1.3B-$28.0M$137.0M$310.0M$5.0B$5.0B10-Q 2026-10-28
Q2 2025
2025-06-30
$1.3B-$62.0M$35.0M$266.0M$5.0B$4.9B10-Q 2026-07-29
Q1 2025
2025-03-31
$1.1B-$212.0M-$25.0M$202.0M$4.8B$4.8B10-Q 2026-04-29
Q4 2024
2024-12-31
$1.3B-$3.0M$22.0M$305.0M$4.8B$4.8B10-K 2026-02-18

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2023-08-02
Latest annual report10-K2026-02-18
Latest quarterly / interim10-Q2026-10-28
Latest current report8-K2026-10-28
Latest proxyDEF 14A2026-04-10

Source: SEC EDGAR submissions feed, 372 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+5.5%
1 month+33.4%
3 months+24.2%
Year to date+23.5%
1 year+34.4%
From 52-week high-1.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Ophthalmic Goods

TickerCompanyPriceDayMarket cap
COOThe Cooper Companies Inc.$61.88-1.23%$11.8B
WRBYWarby Parker Inc.$26.23-4.41%$3.3B
ALCAlcon Inc.$73.64-0.65%$36.8B
EYENational Vision Holdings Inc.$18.74+2.43%$1.5B
STAASTAAR Surgical Company$26.01-1.44%$1.3B
RXSTRxSight Inc.$5.30-0.38%$222.2M
LUCYInnovative Eyewear Inc.$0.7820-3.25%$6.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier